Michelle Lin

Vice President, Preclinical And Translational Biology at Vor Biopharma

Michelle Lin is currently serving as the Vice President of Preclinical and Translational Biology at Vor Bio. Michelle has also held various leadership roles in preclinical sciences and HSC biology at different companies including Vor Bio, CRISPR Therapeutics, and Boston Children's Hospital. Michelle has a strong background in research and development within the field of hematology, particularly in sickle cell disease and β-thalassemia programs. Prior to their industry experience, Michelle worked as a Postdoctoral Fellow at Boston Children's Hospital and as a Research Technician at Cornell University. Michelle holds a PhD in Pharmacology from Yale University and a Bachelor of Arts in Biological Sciences/Physiology from Cornell University.

Links

Previous companies

Cornell University logo
CRISPR Therapeutics logo

Org chart

Timeline

  • Vice President, Preclinical And Translational Biology

    May 1, 2023 - present

  • Vice President, Head of Preclinical Sciences and HSC Biology

    January 1, 2023

  • Senior Director, Head of Preclinical Sciences and HSC Biology

    January, 2022

  • Director, Head of Preclinical Sciences and HSC Biology

    March, 2020

  • Associate Director, Head of Preclinical Sciences and HSC Biology

    November, 2019

  • Associate Director, Discovery Research

    May, 2019

View in org chart